Robert I. Misbin

2.1k total citations
53 papers, 1.3k citations indexed

About

Robert I. Misbin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Robert I. Misbin has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Robert I. Misbin's work include Metabolism, Diabetes, and Cancer (15 papers), Diet and metabolism studies (9 papers) and Pancreatic function and diabetes (9 papers). Robert I. Misbin is often cited by papers focused on Metabolism, Diabetes, and Cancer (15 papers), Diet and metabolism studies (9 papers) and Pancreatic function and diabetes (9 papers). Robert I. Misbin collaborates with scholars based in United States, Switzerland and United Kingdom. Robert I. Misbin's co-authors include Richard J. Santen, E C Almira, Peter W. Stacpoole, Stephen H. Curry, Eloise Harman, Thomas G. Baumgartner, Andrea J. Pulkkinen, Thomas J. Merimee, Thomas D Mehl and DA Willard and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Robert I. Misbin

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert I. Misbin United States	20	415	390	258	229	140	53	1.3k
Walter Ziegler Switzerland	25	733 1.8×	404 1.0×	469 1.8×	291 1.3×	99 0.7×	82	2.5k
Shoichi Nakagawa Japan	18	626 1.5×	357 0.9×	320 1.2×	233 1.0×	145 1.0×	48	1.9k
François Berthézène France	20	540 1.3×	243 0.6×	352 1.4×	162 0.7×	103 0.7×	36	1.6k
J.R.L. Masarei Australia	21	464 1.1×	192 0.5×	245 0.9×	211 0.9×	125 0.9×	60	1.4k
T. R. E. Pilkington United Kingdom	28	455 1.1×	311 0.8×	493 1.9×	677 3.0×	118 0.8×	79	2.2k
R R Williams United States	26	811 2.0×	348 0.9×	543 2.1×	234 1.0×	381 2.7×	62	2.2k
Nathaniel Winer United States	19	434 1.0×	302 0.8×	203 0.8×	195 0.9×	44 0.3×	52	1.6k
F Sereni Italy	20	159 0.4×	528 1.4×	151 0.6×	156 0.7×	67 0.5×	75	1.8k
H. F. Woods United Kingdom	25	470 1.1×	567 1.5×	389 1.5×	377 1.6×	65 0.5×	81	2.5k
H. Eder United States	19	864 2.1×	388 1.0×	651 2.5×	395 1.7×	143 1.0×	49	2.2k

Countries citing papers authored by Robert I. Misbin

Since Specialization

Citations

This map shows the geographic impact of Robert I. Misbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Misbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Misbin more than expected).

Fields of papers citing papers by Robert I. Misbin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Misbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Misbin. The network helps show where Robert I. Misbin may publish in the future.

Co-authorship network of co-authors of Robert I. Misbin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Misbin. A scholar is included among the top collaborators of Robert I. Misbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Misbin. Robert I. Misbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lockwood, D H & Robert I. Misbin. (2009). Proinsulin Content of Adult and Fetal Pancreatic Tissue Extracted after Rapid Freezing in Situ. Hormone and Metabolic Research. 4(4). 232–234.

Misbin, Robert I.. (2007). Lessons From the Avandia Controversy. Diabetes Care. 30(12). 3141–3144. 8 indexed citations

Misbin, Robert I.. (2004). The Phantom of Lactic Acidosis due to Metformin in Patients With Diabetes. Diabetes Care. 27(7). 1791–1793. 135 indexed citations

Portenoy, Russell K., Nessa Coyle, Kathryn M. Kash, et al.. (1997). Determinants of the Wiffingness to Endorse Assisted Suicide. Psychosomatics. 38(3). 277–287. 74 indexed citations

Gueriguian, John L., Lucy Green, Robert I. Misbin, Bruce V. Stadel, & G. Alexander Fleming. (1996). Efficacy of Metformin in Non-Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine. 334(4). 269–270. 7 indexed citations

Misbin, Robert I.. (1991). Physicians' Aid in Dying. New England Journal of Medicine. 325(18). 1307–1311. 34 indexed citations

Almira, E C & Robert I. Misbin. (1989). Effects of insulin and streptozotocin-diabetes on isoproterenol-stimulated cyclic AMP production in myocytes isolated from rat heart. Metabolism. 38(2). 102–103. 3 indexed citations

Misbin, Robert I., Maria B. Grant, Mark S. Pecker, & Steven A. Atlas. (1987). Elevated Levels of Plasma Prorenin (Inactive Renin) in Diabetic and Nondiabetic Patients with Autonomic Dysfunction*. The Journal of Clinical Endocrinology & Metabolism. 64(5). 964–968. 32 indexed citations

Gardner, Donald F, Michael S. Kilberg, M. Michael Wolfe, James E. McGuigan, & Robert I. Misbin. (1985). Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 248(6). G663–G669. 10 indexed citations

10.

Merimee, Thomas J., et al.. (1984). Elevated l-xylulose concentrations in serum: A difference between type I and type II diabetes. Metabolism. 33(1). 82–84. 3 indexed citations

11.

Green, Allan, et al.. (1984). β-Hydroxybutyrate Increases the Insulin Sensitivity of Adipocyte Glucose Transport at a Postreceptor Level. Diabetes. 33(11). 1045–1050. 12 indexed citations

12.

Wolfe, M. Michael, Robert I. Misbin, Donald F Gardner, & James E. McGuigan. (1983). Enteric release of vasoactive intestinal peptide after a peptone meal in the dog. Regulatory Peptides. 5(2). 103–109. 8 indexed citations

13.

Misbin, Robert I., E C Almira, E. R. Froesch, Thomas J. Merimee, & Jürgen Zapf. (1983). Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2. Metabolism. 32(6). 537–539. 6 indexed citations

14.

Misbin, Robert I.. (1981). Dietary Regulation of Insulin Receptors in Obesity. Journal of Nutrition. 111(3). 475–479. 9 indexed citations

15.

Misbin, Robert I., E C Almira, & Michael Cleman. (1981). Insulin Degradation in Serum of a Patient with Apparent Insulin Resistance*. The Journal of Clinical Endocrinology & Metabolism. 52(2). 177–180. 19 indexed citations

16.

Misbin, Robert I., et al.. (1980). Sex Variation in Dietary Regulation of Insulin Receptors in Man. Journal of Nutrition. 110(10). 2109–2112. 2 indexed citations

17.

Merimee, Thomas J., et al.. (1980). Propranolol and Hypoglycemia: The Effects of Beta‐Adrenergic Blockade on Glucose and Alanine Levels During Fasting. The Journal of Clinical Pharmacology. 20(1). 50–58. 8 indexed citations

18.

Misbin, Robert I., J. Patrick O’Leary, & Andrea J. Pulkkinen. (1979). Insulin Receptor Binding in Obesity: A Reassessment. Science. 205(4410). 1003–1004. 27 indexed citations

19.

Misbin, Robert I., et al.. (1978). Ketoacids and the Insulin Receptor. Diabetes. 27(5). 539–542. 21 indexed citations

20.

Misbin, Robert I., et al.. (1972). Tyrosine and glutamic acid in plasma and urine of patients with altered thyroid function. Metabolism. 21(9). 855–865. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact